These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30639799)

  • 1. Juvenile transient bone marrow oedema of the foot associated with Vitamin D deficiency: A case study and an overview of pathogenesis and treatment.
    Kaspiris A; Savvidou OD; Chrronopoulos E; Vasiliadis E
    Foot (Edinb); 2019 Mar; 38():50-53. PubMed ID: 30639799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Prevalence of Vitamin D Deficiency in Patients With Bone Marrow Edema Syndrome of the Foot and Ankle.
    Horas K; Fraissler L; Maier G; Jakob F; Seefried L; Konrads C; Rudert M; Walcher M
    Foot Ankle Int; 2017 Jul; 38(7):760-766. PubMed ID: 28340550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of vitamin D and other bone metabolism parameters as risk factors for primary bone marrow oedema syndrome.
    Oehler N; Mussawy H; Schmidt T; Rolvien T; Barvencik F
    BMC Musculoskelet Disord; 2018 Dec; 19(1):451. PubMed ID: 30579337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Juvenile bone-marrow oedema of the acetabulum treated by iloprost.
    Aigner N; Petje G; Schneider W; Krasny C; Grill F; Landsiedl F
    J Bone Joint Surg Br; 2002 Sep; 84(7):1050-2. PubMed ID: 12358371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient bone marrow edema of the foot and ankle and its association with reduced systemic bone mineral density.
    Sprinchorn AE; O'Sullivan R; Beischer AD
    Foot Ankle Int; 2011 May; 32(5):S508-12. PubMed ID: 21733459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous bisphosphonates and vitamin D in the treatment of bone marrow oedema in professional athletes.
    Simon MJ; Barvencik F; Luttke M; Amling M; Mueller-Wohlfahrt HW; Ueblacker P
    Injury; 2014 Jun; 45(6):981-7. PubMed ID: 24552768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Denosumab is effective in the treatment of bone marrow oedema syndrome.
    Rolvien T; Schmidt T; Butscheidt S; Amling M; Barvencik F
    Injury; 2017 Apr; 48(4):874-879. PubMed ID: 28242067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of bone-marrow oedema of the talus with the prostacyclin analogue iloprost. An MRI-controlled investigation of a new method.
    Aigner N; Petje G; Steinboeck G; Schneider W; Krasny C; Landsiedl F
    J Bone Joint Surg Br; 2001 Aug; 83(6):855-8. PubMed ID: 11521928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of migrating bone marrow edema syndrome in a patient with Behcet's disease.
    Kwon HY; Park W; Kwon SR; Lim MJ; Kim YJ; Joo K; Lim JH; Jung KH
    Int J Rheum Dis; 2014 May; 17(4):483-5. PubMed ID: 24618034
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevalence of bone marrow edema in a study population with foot and/or ankle pain.
    González-Martín D; Herrera-Pérez M; Martín-Vélez P; Rendón-Díaz D
    Foot (Edinb); 2019 Sep; 40():76-80. PubMed ID: 31136917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Considerations Regarding Vitamin D in Foot and Ankle Treatment and Surgery.
    Michelson JD
    Orthop Clin North Am; 2024 Jul; 55(3):383-392. PubMed ID: 38782509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Idiopathic bone marrow oedema: Outcome of 3 cases treated with denosumab].
    Zaldibar Barinaga MB; Reoyo Díez JI
    Rehabilitacion (Madr); 2019; 53(2):126-130. PubMed ID: 31186095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary bone marrow oedema syndromes.
    Patel S
    Rheumatology (Oxford); 2014 May; 53(5):785-92. PubMed ID: 24080251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of long-term nonsteroidal antiinflammatory drug treatment on magnetic resonance imaging-determined bone marrow oedema in early, active axial spondyloarthritis patients.
    Tang M; Xue L; Shen Y; Bo L; Yang R; Wen J; Zhang Y; Liu Z; Fu J
    Clin Rheumatol; 2018 Jan; 37(1):245-250. PubMed ID: 28497237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical Considerations for Vitamin D Deficiency in Foot and Ankle Surgery.
    DeFontes K; Smith JT
    Orthop Clin North Am; 2019 Apr; 50(2):259-267. PubMed ID: 30850083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iloprost for the treatment of bone marrow edema in the hindfoot.
    Aigner N; Meizer R; Stolz G; Petje G; Krasny C; Landsiedl F; Steinboeck G
    Foot Ankle Clin; 2003 Dec; 8(4):683-93. PubMed ID: 14719835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the effect of vitamin D level on greater tuberosity primary bone marrow edema.
    Başbuğ V; Yaka H; Tekin AA; Duman N; Demiryürek M; Özer M
    J Orthop Res; 2023 Nov; 41(11):2367-2371. PubMed ID: 37122199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance imaging findings in 84 patients with early rheumatoid arthritis: bone marrow oedema predicts erosive progression.
    Haavardsholm EA; Bøyesen P; Østergaard M; Schildvold A; Kvien TK
    Ann Rheum Dis; 2008 Jun; 67(6):794-800. PubMed ID: 17981915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of transient bone marrow oedema of the hip--a comparative study.
    Radke S; Kirschner S; Seipel V; Rader C; Eulert J
    Int Orthop; 2003; 27(3):149-52. PubMed ID: 12799758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin C deficiency mimicking inflammatory bone disease of the hand.
    Liebling EJ; Sze RW; Behrens EM
    Pediatr Rheumatol Online J; 2020 Jun; 18(1):45. PubMed ID: 32517792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.